Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > December 2008 - Volume 20 - Issue 12 > Adefovir combined with hepatitis C virus treatment may preve...
European Journal of Gastroenterology & Hepatology:
December 2008 - Volume 20 - Issue 12 - pp 1235-1237
doi: 10.1097/MEG.0b013e328305ba2a
Case Reports

Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers

Renou, Christophe; Cadranel, Jean-François; Pariente, Alexandre; Pénaranda, Guillaume; Bourlière, Marc; Halfon, Philippe; Igual, Jean-Pierre; Harafa, Abdelouahid; Muller, Pierre; Bertrand, Jean-Jacques; Laugier, René

Collapse Box

Abstract

This observation reports that a hepatitis B virus (HBV) reactivation, as the result of hepatitis C virus (HCV) eradication on a dominant HCV coinfected HBV/HCV patient, was subsequently prevented by treating both viral infections together. This finding raises the question as to whether preemptive HBV treatment should be prescribed along with HCV treatment to prevent HBV from being reactive after HCV eradication in coinfected HBV/HCV patients.

© 2008 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.